Business
Up 36% in a year, why this $8 billion ASX 200 stock has still a ‘strong growth forecast’
Image source: Getty Images
Looking for a quality, under-the-radar S&P/ASX 200 Index (ASX: XJO) stock with strong forecast revenue growth?
Then you may want to check out Telix Pharmaceuticals Ltd (ASX: TLX).
Shares in the diagnostic and therapeutic product developer closed on Friday trading for…
Continue Reading
-
Noosa News21 hours agoWhat Halloween decoration is accused of endangering birds? Take the Brisbane Times Quiz
-
Noosa News23 hours agoGutted Broadway Hotel in Woolloongabba set for restoration … and a new high-rise tower
-
Noosa News23 hours agoGold Coast tradie becomes hero after crash-tackling armed robbery suspect at Biggera Waters petrol station
-
General11 hours agoDemography Manifest